So 91 percent of the individuals in this study had the APOE4,4 variant and Alzheimers
Conclusion Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms in AD models, such as anti-inflammation, anti-oxidative stress, reducing A aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects
Thus we use Non Coated Fish Oil capsules.
Severe cases can even lead to fainting or seizures
Additional testing: Your provider may order fasting insulin, HOMA-IR, or other tests based on your specific situation